STAMBP and acute respiratory distress syndrome: Moreover, different clinical studies have investigated efficacy of ACTH and NDP-α-MSH therapies in systemic inflammatory diseases, including ARDS, rheumatoid arthritis, multiple sclerosis (MS), lupus erythematosus (SLE), kidney diseases, and nephrotic syndromes (70–72).